Suppression of aggregate formation of mutant huntingtin potentiates CREB-binding protein sequestration and apoptotic

Yong-Joon Choi1, Song-In Kim, Jae-Won Lee

  • 1Department of Pharmacology, College of Medicine, Kangwon National University, Chuncheon, South Korea.

Insights

Mutant huntingtin aggregates are hallmarks of Huntington's disease (HD), but non-aggregate forms may also drive pathogenesis. This study reveals that even non-aggregated mutant huntingtin can sequester CBP, leading to apoptosis and decreased PGC1-α expression in HD.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Huntington's disease (HD) is characterized by mutant huntingtin aggregates.
  • The role of these aggregates and mutant huntingtin in HD pathogenesis is not fully understood.
  • Sequestration of CBP by mutant huntingtin is implicated in HD, but the necessity of aggregate formation for this process is unclear.

Purpose of the Study:

  • To investigate whether mutant huntingtin aggregate formation is essential for CBP sequestration and subsequent pathogenic events in HD.
  • To explore the pathogenic role of non-aggregate forms of mutant huntingtin.

Main Methods:

  • Engineered N-terminal and C-terminal YFP-tagged exon 1 huntingtin constructs to modulate aggregation propensity.
  • Assessed aggregation frequency, CBP sequestration, apoptosis, and gene expression changes (microarray, PGC1-α levels).

Main Results:

  • C-terminally tagged huntingtin (MT-YFP) showed efficient aggregation.
  • N-terminally tagged huntingtin (YFP-MT) exhibited significantly reduced aggregation but increased CBP sequestration and apoptosis.
  • Microarray analysis revealed transcriptional changes favoring apoptosis.
  • PGC1-α expression was significantly decreased in YFP-MT.

Conclusions:

  • Microscopically non-aggregate forms of mutant huntingtin can exert essential pathogenic roles in Huntington's disease.
  • Aggregate formation may not be strictly necessary for all pathogenic mechanisms of mutant huntingtin, such as CBP sequestration and apoptosis induction.

Related Concept Videos

Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...